Center calls for stronger federal regulation of genetic testingNovember 30, 2005The Genetics and Public Policy Center this week called on Mark McClellan, Administrator of the Centers for Medicare and Medicaid Services (CMS), to end years of delay in assuring the safety and accuracy of genetic testing by issuing a proposed rule to create a genetic testing specialty under the Clinical Laboratory Improvement Amendments (CLIA) of 1988. The delay has meant that scientific and technological advances in genetic testing have outpaced the government's ability to provide adequate oversight, maintains the Center, which was established by The Pew Charitable Trusts through Johns Hopkins University. CMS, an agency of the U.S. Department of Health and Human Services, administers standards for diagnostic laboratory testing, such as those used for blood sugar, urinalysis, or HIV infection, to ensure that the tests are accurate and reliable and that physical conditions at the laboratories meet certain expectations. "For more than ten years, federal advisory committees have been calling upon the government to provide more oversight of genetic tests," the letter to McClellan from the Center notes. CMS responded to the growing sense of urgency to improve genetic testing oversight five years ago by issuing a Notice of Intent of proposed rulemaking that incorporated recommendations from a federal advisory group regarding development of a genetic testing specialty. "More than five years later, nothing has been issued by (CMS)," the letter says. During the same period, the genetic testing industry has grown dramatically; today, more than 800 genetics tests are available clinically, and many more are in development. "These genetic tests may be the basis for profound life decisions, such as whether to undergo prophylactic mastectomy, terminate a pregnancy, or take a certain drug or certain dosage of a drug," according to the letter. Under CLIA, CMS is charged with developing standards for how medical laboratory tests are conducted, the training and proficiency of laboratory personnel, and other standards to ensure the quality of clinical tests. The problem, says Center policy analyst Gail Javitt, an author of the letter, is that CLIA did not include a genetic testing specialty for the then-nascent field of genetic testing as part of its oversight regime. "The absence of a specialty area for genetic testing with specifically tailored requirements for the now-burgeoning genetic testing industry hampers CLIA's ability to oversee the quality of genetic testing and adequately to ensure its safety," she writes. "We urge CMS to take immediate steps to issue proposed regulations for a genetic testing specialty." The Center reviewed all the comments that were collected by CMS five years ago in response to the Notice of Intent, Javitt explains. "There were no showstoppers here in terms of issues central to the regulation," she says. "Rather, we found substantial support for the creation of a genetic testing specialty." There were specific concerns about a few of the proposed requirements detailed in the Notice of Intent, she explained, but these that could be left out of the final rule without unduly weakening the regulation. "A genetic testing specialty is achievable if it focuses on key quality requirements such as analytic and clinical validity of the tests and proficiency standards for laboratory personnel," she added. "The government has been dragging its feet for more than 10 years about improving the quality of genetic testing," she said. "It's time to move swiftly to protect the American public and publish a proposed rule." Genetics & Public Policy Center, Johns Hopkins Uni |
|||||||||||||||||||||
| Related Genetic Testing Current Events and Genetic Testing News Articles Autism Consortium symposium draws record number of researchers, advocates, parents for autism update The Autism Consortium, an innovative collaboration of researchers, clinicians, funders and families dedicated to catalyzing research and enhancing clinical care for autism spectrum disorders (ASDs), held its fourth annual symposium on October 28th, 2009, at Harvard Medical School in Boston. Experts unveil new CVD guidelines and position papers Several new guidelines and position papers offering the most up to date information to ensure that clinicians practice evidence-based medicine were released at the Canadian Cardiovascular Congress 2009 this week. 1 shot of gene therapy and children with congenital blindness can now see Born with a retinal disease that made him legally blind, and would eventually leave him totally sightless, the nine-year-old boy used to sit in the back of the classroom, relying on the large print on an electronic screen and assisted by teacher aides. Gene mingling increases sudden death risk A multi-national research team has discovered that two genetic factors converge to increase the risk of sudden cardiac death. Dartmouth researchers get personal with genetics Two recent studies by Dartmouth researchers use individual genetic data to reveal the powers and limits of our current understanding of how the genome influences human health and what genes can reveal about the ancestry of the people of New Hampshire. Fear of insurance rejection deters potentially life saving genetic tests for bowel cancer An Australian study of families with genetic risk of bowel cancer has found that 50 percent of participants declined genetic testing when informed of insurance implications. Race/ethnicity, family income and education associated with sugar consumption The intake of added sugars in the United States is excessive, estimated by the US Department of Agriculture in 1999-2002 as 17% of calories a day. Genetic Testing May Be Valuable in Treating Colorectal Cancer For the 29,000 patients in the United States with metastatic colorectal cancer, chemotherapy with irinotecan is a standard treatment that has been shown to improve survival. Scientists discover gene mutation responsible for hereditary neuroendocrine tumor University of Utah researchers and their colleagues have identified the gene that is mutated in a hereditary form of a rare neuroendocrine tumor called paraganglioma (PGL). Pre-chewed food could transmit HIV Researchers have uncovered the first cases in which HIV almost certainly was transmitted from mothers or other caregivers to children through pre-chewed food. More Genetic Testing Current Events and Genetic Testing News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||